Banking/Financial Service

Zhihu Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024

BEIJING, March 13, 2024 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390), a leading online content community inChina, today announced that it will report its unaudited financial results for the quarter and full year endedDecember 31, 2023 before the U.S. market opens o...

2024-03-13 17:52 4277

JinkoSolar to Report Fourth Quarter and Full Year 2023 Results on March 20, 2024

SHANGRAO, China, March 13, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it plans to release its unaudited financial results for the fourth quarter...

2024-03-13 15:27 4034

The Inner Mountain Foundation Joins DHgate to Empower Female Entrepreneurs at ASD Market Week

LAS VEGAS, March 12, 2024 /PRNewswire/ -- The Inner Mountain Foundation , the newly-launched global women's empowerment organization, is excited to join this year'sASD Market Week in Las Vegas to introduce its US chapter to ASD visitors alongs...

2024-03-13 08:52 2703

MoEngage Debuts in the Real-Time Interaction Management Report by Independent Research Firm

SAN FRANCISCO, March 12, 2024 /PRNewswire/ -- MoEngage, the insights-led customer engagement platform, has debuted in The Forrester Wave™: Real-Time Interaction Management, Q1 2024 report under the "Contenders" category. MoEngage has received top scores across the digital marketing and experience...

2024-03-13 00:00 3057

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin")...

2024-03-12 20:30 4039

GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%

R&D Innovation to Lead the Future, Deepening Customer Value Creation * Sustained High Revenue Growth: GenScript Group's five-year CAGR stands at an impressive 30%, with a strong global operation and stable cash flow. In 2023, the group's best-in-class cell therapy product CARVYKTI®, achieved sa...

2024-03-12 20:15 3791

Lufax to Announce Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

SHANGHAI, March 12, 2024 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners inChina, today announced that it plans to release its fourth quarter and fiscal year 2023 financial results before the ma...

2024-03-12 19:00 3613

Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders

* Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a$12.50 trading price * Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close * Upon closing, Baird Medical is expected to trade...

2024-03-12 19:00 3293

ATRenew Announces US$20 Million Share Repurchase Program

SHANGHAI, March 12, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced that its board of directors has authorized a share repurchase program, under whic...

2024-03-12 16:00 3243

ATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2023 Financial Results

SHANGHAI, March 12, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced its unaudited financial results for the fourth quarter and full year endedDecembe...

2024-03-12 16:00 3351

MINISO Group Announces December Quarter 2023 Unaudited Financial Results

GUANGZHOU, China, March 12, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced its unaudited financial results for the ...

2024-03-12 12:15 3734

Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®

SHANGHAI, March 11, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced that the U.S. FDA has granted an orphan drug exclusivity period of seven years for...

2024-03-12 09:28 5217

Casio to Release Uterocervical Observation Camera in the United States, Australia and New Zealand

FDA Registration Completed in the United States and TGA Approval Obtained in Australia TOKYO, March 11, 2024 /PRNewswire/ -- Casio Computer Co., Ltd. announced today that the DZ-C100 COLPOCAMERA, which is designed for uterocervical observation and photography in gynecological settings, and the C...

2024-03-12 09:00 2687

Cango Inc. Reports Fourth Quarter and Full Year 2023 Unaudited Financial Results

SHANGHAI, March 11, 2024 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform inChina, today announced its unaudited financial results for the fourth quarter and full year of 2023. Fourth Quarter 2023 Financial and Operational High...

2024-03-12 05:30 3228

Yalla Group Limited Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results

DUBAI, UAE, March 11, 2024 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the largestMiddle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results for the fourth quarter and full year endedDecem...

2024-03-12 05:00 3486

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, March 11, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of$50,000 has been deposited into the Company's trust account to further extend the period of time the Company has to consummate its business combination by a...

2024-03-12 04:30 2891

Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London

SHANGHAI, March 11, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present its next generation ADC platform IDDC™ and the latest study results of multiple novel ADCs (9MW2821, 7MW3711, 9MW2921) developed...

2024-03-11 22:00 2368

Yiren Digital to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024

BEIJING, March 11, 2024 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services inChina, announced that it plans to release its unaudited financial results for the fourth quarter ...

2024-03-11 20:35 3573

Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout

BOSTON, March 11, 2024 /PRNewswire/ -- Medicilon, a one-stop pharmaceutical preclinical research and developmentCRO can simultaneously meet Chinese and American drug discovery and development needs (including GLP standards) promptly and efficiently with fast initiation times.Over the past 20 year...

2024-03-11 20:30 2774

TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer

* TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab * TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co.,...

2024-03-11 20:00 2586
1 ... 168169170171172173174 ... 383

Week's Top Stories